Suit Challenges FDA's Authority Over Cancer Drugs
A U.S. circuit court is set to hear arguments Thursday on whether terminally ill patients should be allowed access to drugs not approved by the U.S. Food and Drug Administration....To view the full article, register now.
Already a subscriber? Click here to view full article